Hillrom (NYSE: HRC) stock rocketed today after a Wall Street Journal report that Baxter (NYSE: BAX) is in the early stages of talks to acquire the company. WSJ cited people familiar with the matter, who added that there was no guarantee the two companies will reach an agreement. HRC shares are up 8.7% to $134.49 […]
Hillrom
Report: Medtech dollars, deals hit new highs in first half of 2021
Fueled at least in part by exceptionally strong IPO and M&A markets, hedge funds, venture capitalists, private equity firms and corporate investors are committing more time and money into privately held medical devices companies, according to a new “Healthcare Investments and Exits” report issued by Silicon Valley Bank. The report examining the first half of […]
MedTech 100 roundup: Industry shatters all-time best with remarkable rise
The medtech industry’s steady growth provided optimism in recent weeks, but an unforeseen leap sees it hitting new heights now. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (July 16) at 145.88 points, a remarkable 27.1% rise week-over-week, registering by far the greatest increase the […]
Court orders Hillrom to proceed with BardyDx acquisition
The Court of Chancery in the state of Delaware ordered Hillrom (NYSE:HRC) to complete its planned acquisition of BardyDx. In March, Hillrom reversed course on the planned $375 million acquisition of Bardy Diagnostics and its Carnation Ambulatory Monitor, or CAM patch, claiming that closing conditions weren’t met. Hillrom’s u-turn came in the wake of regional […]
Hillrom dips despite Street-beating Q2, raised guidance
Hillrom (NYSE:HRC) shares dipped slightly despite second-quarter results that beat the consensus forecast. The Chicago-based company posted profits of $87.1 million, or $1.30 per share, on sales of $762 million for the three months ended March 31, 2021, for an 85.7% bottom-line gain on sales growth of 5.4%. Adjusted to exclude one-time items, earnings per […]
MedTech 100 roundup: Industry sees largest fall since October
The medtech industry’s hot start to 2021 has finally come to a full halt after stocks fell harder than they had in more than four months. MassDevice‘s MedTech 100 index ended the week (March 5) at 103.3 points, marking a -3.1% dip from the 106.65-point mark set one week before (Feb. 26). In less than a […]
DTW Podcast: Can AI, advanced imaging and robotics ‘democratize’ surgery?
A new generation of digital surgery systems will level surgeons’ playing field — giving them artificial intelligence, robotic tools, and other assistive technologies. In three interviews in this week’s DeviceTalks Weekly Podcast, leaders from Asensus, ActivSurgical and Memic explain how their systems will improve surgeon performance, reduce errors, and deliver the “democratization” of surgical robotics. […]
Hillrom execs change their minds on BardyDx acquisition
Hillrom (NYSE:HRC) says closing conditions have not been met when it comes to the company’s previously planned $375 million acquisition of Bardy Diagnostics and its Carnation Ambulatory Monitor, or CAM patch. In response, BardyDx has sued Hillrom in the Delaware Court of Chancery, asking the court to order the merger to proceed because Hillrom’s argument […]
Hillrom has a serious overhead lift recall
FDA has designated Hillrom’s recall of its Liko Multirall 200 overhead lift as Class I, its most serious level. Hillrom (NYSE:HRC) initiated the recall on Dec. 18, 2020. It involves 11,600 devices, which are used to move patients from room to room. The recalled devices have a risk of the Q-link strap locks not attaching to […]
These 5 medtech companies made it into the top 200 of Forbes’ best places to work list
Johnson & Johnson, Steris, Philips, Fujifilm Holdings and Boston Scientific were recently named among Forbes’ best large employers in America, based on feedback from their employees. Forbes partnered with a market research firm to survey 50,000 Americans working for businesses with at least 1,000 employees. Survey participants were asked to rate their willingness to recommend their employer […]
Hillrom beats The Street in Q1, raises 2021 guidance
Hillrom (NYSE:HRC) shares remain up after Street-beating first-quarter results and a raised 2021 guidance. The Chicago-based company posted profits of $58 million, or 88¢ per share, on sales of $741.1 million for the three months ended Dec. 31, 2020, for a 47.7% bottom-line gain on sales growth of 8.2%. Adjusted to exclude one-time items, earnings […]